Almost Family reports record net program revenues of $96.

Our effective tax price for the fourth one fourth of 2013 was 78.6 percent in comparison to 40.1 percent for the fourth one fourth of 2012, due to certain deal and purchase costs that aren’t currently deductible and that do not bring about the establishment of a deferred tax asset.5 percent and also have used that rate in the presentation of income and diluted EPS from continuing operations. December 31 Full Year Ended, 2013 Almost Family reported full year outcomes that included the influence of the following acquisitions, in comparison with our results for the full calendar year of 2012: The July 19, 2013 acquisition of Indiana Home Treatment Network added $5.0 million of revenue to the VN segment and $0.07 to diluted EPS from continuing operations Because they occurred in the fourth quarter of 2013, the impact of SunCrest and Imperium for the entire year was the same as for the fourth quarter In addition to your acquisition activity, Medicare rate cuts, primarily sequestration, reduced revenue and working income by $4.4 million and diluted EPS from continuing operations by $0.28.2 percent.8 percent and 5.1 percent, respectively., a biopharmaceutical firm focused on innovative remedies that address unmet medical needs in neurological and related central nervous system disorders, today announced outcomes of preclinical studies, which suggest that pimavanserin, ACADIA’s proprietary product candidate currently in Stage III development for Parkinson’s disease psychosis, may have also therapeutic benefits in the treating Alzheimer’s disease psychosis .